HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016
Top Cited Papers
- 19 October 2018
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in Morbidity and Mortality Weekly Report (MMWR)
- Vol. 67 (41), 1147-1150
- https://doi.org/10.15585/mmwr.mm6741a3
Abstract
A new CDC analysis found that during 2014–2016 the number of U.S. residents who filled a prescription for preexposure prophylaxis (PrEP) increased substantially, but remained a small fraction of the estimated 1.1 million U.S. residents who could benefit from PrEP.Keywords
This publication has 6 references indexed in Scilit:
- Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015Annals of Epidemiology, 2018
- Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons—United States, 2010–2014Clinical Infectious Diseases, 2016
- Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet, 2013
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in BotswanaThe New England Journal of Medicine, 2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenThe New England Journal of Medicine, 2012
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenThe New England Journal of Medicine, 2010